$HSTM
HealthStream Inc

2017 Q2 Form 10-Q Financial Statement

#000119312517242423 Filed on July 31, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $61.48M $54.79M
YoY Change 12.21% 5.08%
Cost Of Revenue $21.22M $22.62M
YoY Change -6.18% 0.85%
Gross Profit $40.26M $32.17M
YoY Change 25.14% 8.27%
Gross Profit Margin 65.48% 58.71%
Selling, General & Admin $16.74M $17.53M
YoY Change -4.51% 2.65%
% of Gross Profit 41.58% 54.49%
Research & Development $6.151M $7.244M
YoY Change -15.09% 24.57%
% of Gross Profit 15.28% 22.52%
Depreciation & Amortization $6.001M $5.081M
YoY Change 18.11% 19.38%
% of Gross Profit 14.91% 15.79%
Operating Expenses $6.151M $7.244M
YoY Change -15.09% -68.36%
Operating Profit $2.801M $2.316M
YoY Change 20.94% -9.67%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $165.0K $109.0K
YoY Change 51.38% -347.73%
Pretax Income $2.966M $2.425M
YoY Change 22.31% -3.77%
Income Tax $741.0K $1.022M
% Of Pretax Income 24.98% 42.14%
Net Earnings $2.266M $1.403M
YoY Change 61.51% -4.75%
Net Earnings / Revenue 3.69% 2.56%
Basic Earnings Per Share $0.07 $0.04
Diluted Earnings Per Share $0.07 $0.04
COMMON SHARES
Basic Shares Outstanding 31.88M 31.74M shares
Diluted Shares Outstanding 32.23M 32.07M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $115.7M $138.8M
YoY Change -16.64% -0.79%
Cash & Equivalents $54.55M $66.80M
Short-Term Investments $61.10M $72.00M
Other Short-Term Assets $9.306M $8.312M
YoY Change 11.96% 27.66%
Inventory
Prepaid Expenses
Receivables $37.15M $42.01M
Other Receivables $0.00 $0.00
Total Short-Term Assets $181.8M $204.5M
YoY Change -11.11% 2.83%
LONG-TERM ASSETS
Property, Plant & Equipment $10.26M $11.14M
YoY Change -7.86% -1.28%
Goodwill $109.8M $88.63M
YoY Change 23.85% 5.52%
Intangibles
YoY Change
Long-Term Investments $3.300M $3.600M
YoY Change -8.33% 28.57%
Other Assets $773.0K $375.0K
YoY Change 106.13% -69.19%
Total Long-Term Assets $216.0M $172.7M
YoY Change 25.08% 0.12%
TOTAL ASSETS
Total Short-Term Assets $181.8M $204.5M
Total Long-Term Assets $216.0M $172.7M
Total Assets $397.8M $377.2M
YoY Change 5.46% 1.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.60M $1.742M
YoY Change 738.12% -42.87%
Accrued Expenses $11.20M $10.96M
YoY Change 2.19% 13.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $92.90M $81.74M
YoY Change 13.64% -6.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.339M $1.069M
YoY Change 25.26% -58.85%
Total Long-Term Liabilities $1.339M $1.069M
YoY Change 25.26% -58.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $92.90M $81.74M
Total Long-Term Liabilities $1.339M $1.069M
Total Liabilities $94.23M $82.81M
YoY Change 13.79% -7.54%
SHAREHOLDERS EQUITY
Retained Earnings $11.09M $4.494M
YoY Change 146.77% -258.52%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $292.6M $284.1M
YoY Change
Total Liabilities & Shareholders Equity $397.8M $377.2M
YoY Change 5.46% 1.57%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $2.266M $1.403M
YoY Change 61.51% -4.75%
Depreciation, Depletion And Amortization $6.001M $5.081M
YoY Change 18.11% 19.38%
Cash From Operating Activities $6.510M -$5.420M
YoY Change -220.11% -153.56%
INVESTING ACTIVITIES
Capital Expenditures -$5.290M -$2.860M
YoY Change 84.97% -12.8%
Acquisitions
YoY Change
Other Investing Activities $180.0K -$7.730M
YoY Change -102.33% -86.2%
Cash From Investing Activities -$5.110M -$10.58M
YoY Change -51.7% -82.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 110.0K 20.00K
YoY Change 450.0% -99.97%
NET CHANGE
Cash From Operating Activities 6.510M -5.420M
Cash From Investing Activities -5.110M -10.58M
Cash From Financing Activities 110.0K 20.00K
Net Change In Cash 1.510M -15.98M
YoY Change -109.45% -181.03%
FREE CASH FLOW
Cash From Operating Activities $6.510M -$5.420M
Capital Expenditures -$5.290M -$2.860M
Free Cash Flow $11.80M -$2.560M
YoY Change -560.94% -119.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31886772 shares
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66803000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1188000
CY2017Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
11210000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
181786000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37149000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23938000
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14552000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36000
CY2017Q2 us-gaap Assets
Assets
397775000
CY2017Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
61142000
CY2017Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
36501000
CY2017Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
18346000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54551000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31887000 shares
CY2017Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
281570000
CY2017Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31887000 shares
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
67133000
CY2017Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4446000
CY2017Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
6471000
CY2017Q2 us-gaap Goodwill
Goodwill
109765000
CY2017Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3271000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
397775000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
92895000
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
9306000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
773000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1339000
CY2017Q2 us-gaap Prepaid Royalties
PrepaidRoyalties
16954000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10263000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11090000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
292624000
CY2017Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2684000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82010000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
863000
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
13161000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
177437000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44805000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20527000
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13267000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-51000
CY2016Q4 us-gaap Assets
Assets
396000000
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
53540000
CY2016Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
31787000
CY2016Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
16310000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49634000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31748000 shares
CY2016Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
280813000
CY2016Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31748000 shares
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
68542000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5968000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7859000
CY2016Q4 us-gaap Goodwill
Goodwill
109765000
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3276000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
396000000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
94970000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8694000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
603000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1095000
CY2016Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
18183000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10245000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5346000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
286108000
CY2016Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2581000
dei Amendment Flag
AmendmentFlag
false
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
919000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
87000 shares
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
919000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4917000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3567000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
52651000
us-gaap Costs And Expenses
CostsAndExpenses
116662000
us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
2192000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
416000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12918000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.287 pure
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
419000
dei Entity Central Index Key
EntityCentralIndexKey
0001095565
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4984000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2796000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-1951000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1717000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
170000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
341000 shares
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1432000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
610000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
-1228000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7029000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-17965000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
23044000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-162000
us-gaap Net Income Loss
NetIncomeLoss
3552000
us-gaap Operating Income Loss
OperatingIncomeLoss
4689000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
15000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
16460000
us-gaap Other Noncash Expense
OtherNoncashExpense
264000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
295000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
392000
us-gaap Payments For Software
PaymentsForSoftware
6238000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3876000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
48861000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
41010000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
230000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
523000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13640000
us-gaap Sales Revenue Net
SalesRevenueNet
121351000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20993000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-162000
us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
0 shares
dei Trading Symbol
TradingSymbol
HSTM
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32166000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31825000 shares
hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
3 Incentive_Plan
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-208000
us-gaap Net Income Loss
NetIncomeLoss
2903000
us-gaap Operating Income Loss
OperatingIncomeLoss
4802000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
56000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
16505000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1004000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
53000 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15207000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2959000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
45522000
us-gaap Costs And Expenses
CostsAndExpenses
104069000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
932000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10221000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.411 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4929000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6474000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-919000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2806000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-552000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
320000 shares
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-76000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2026000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1123000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
-794000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5722000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15284000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
285000
us-gaap Other Noncash Expense
OtherNoncashExpense
607000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
127000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
302000
us-gaap Payments For Software
PaymentsForSoftware
4303000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3141000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3234000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
71220000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
65639000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
975000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
94000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
240000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14263000
us-gaap Sales Revenue Net
SalesRevenueNet
108871000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17558000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32021000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31701000 shares
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
505000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21250 shares
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1403000
CY2016Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
22622000
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
52477000
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5081000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2425000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
335000 shares
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1022000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
1403000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2316000
CY2016Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8529000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
109000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7244000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
54793000
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9001000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32071000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31736000 shares
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
478000
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30500 shares
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2279000
CY2017Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
26375000
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
58626000
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6531000
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3020000
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
353000 shares
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
754000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
2266000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2855000
CY2017Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
13000
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
13000
CY2017Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8520000
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
165000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7041000
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
61481000
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10159000
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32229000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31876000 shares

Files In Submission

Name View Source Status
0001193125-17-242423-index-headers.html Edgar Link pending
0001193125-17-242423-index.html Edgar Link pending
0001193125-17-242423.txt Edgar Link pending
0001193125-17-242423-xbrl.zip Edgar Link pending
d408430d10q.htm Edgar Link pending
d408430dex101.htm Edgar Link pending
d408430dex311.htm Edgar Link pending
d408430dex312.htm Edgar Link pending
d408430dex321.htm Edgar Link pending
d408430dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g408430g0401065304837.jpg Edgar Link pending
g408430g0401065319783.jpg Edgar Link pending
g408430g0401065332716.jpg Edgar Link pending
hstm-20170630.xml Edgar Link completed
hstm-20170630.xsd Edgar Link pending
hstm-20170630_cal.xml Edgar Link unprocessable
hstm-20170630_def.xml Edgar Link unprocessable
hstm-20170630_lab.xml Edgar Link unprocessable
hstm-20170630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending